13F HOLDINGS REPORT
ACUTA CAPITAL PARTNERS, LLC
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001104659-24-089377
Total Value
$118.7M
Positions
33
Other Managers
0
Confidential Omitted
No
Holdings (33)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | OCULAR THERAPEUTIX INC | OCUL | 2,771,130 | $19.0M | 15.96% |
| 2 | ENLIVEN THERAPEUTICS INC | ELVN | 397,698 | $9.3M | 7.83% |
| 3 | VAXCYTE INC | PCVX | 110,400 | $8.3M | 7.02% |
| 4 | DYNE THERAPEUTICS INC | DYN | 212,500 | $7.5M | 6.32% |
| 5 | PRAXIS PRECISION MEDICINES I | PRAX | 164,431 | $6.8M | 5.73% |
| 6 | CRINETICS PHARMACEUTICALS | CRNX | 135,141 | $6.1M | 5.10% |
| 7 | ROCKET PHARMACEUTICALS INC | RCKTW | 250,370 | $5.4M | 4.54% |
| 8 | TAYSHA GENE THERAPIES INC | TSHA | 2,330,937 | $5.2M | 4.40% |
| 9 | REVOLUTION MEDICINES INC | RVMDW | 133,000 | $5.2M | 4.35% |
| 10 | INSMED INC | INSM | 72,100 | $4.8M | 4.07% |
| 11 | SAREPTA THERAPEUTICS INC | SRPT | 27,500 | $4.3M | 3.66% |
| 12 | TOURMALINE BIO INC | 89157D105 | 269,614 | $3.5M | 2.92% |
| 13 | AGIOS PHARMA | AGIO | 78,700 | $3.4M | 2.86% |
| 14 | KURA ONCOLOGY INC. COMMON STOCK | KURA | 163,000 | $3.4M | 2.83% |
| 15 | MERSANA THERAPEUTICS INC | 59045L106 | 1,663,000 | $3.3M | 2.82% |
| 16 | CORBUS PHARMACEUTICALS HOLDI | CRBP | 64,500 | $2.9M | 2.46% |
| 17 | AADI BIOSCIENCES INC | WHWK | 1,849,402 | $2.7M | 2.27% |
| 18 | VIRIDIAN THERAPEUTICS INC | VRDN | 199,433 | $2.6M | 2.19% |
| 19 | TERNS PHARMACEUTICALS INC | TERN | 369,280 | $2.5M | 2.12% |
| 20 | MEREO BIOPHARMA GROUP PL-ADR | MREO | 677,000 | $2.4M | 2.05% |
| 21 | ARCELLX INC | ACLX | 42,200 | $2.3M | 1.96% |
| 22 | HELIX ACQUISITION CORP II | HLXC | 177,836 | $1.8M | 1.53% |
| 23 | ARGENX SE | ARGX | 4,000 | $1.7M | 1.45% |
| 24 | TREVI THERAPEUTICS INC | TRVI | 260,000 | $774,800 | 0.65% |
| 25 | CELCUITY INC | CELC | 45,000 | $737,100 | 0.62% |
| 26 | ORIC PHARMACEUTICALS INC | ORIC | 96,000 | $678,720 | 0.57% |
| 27 | PLIANT THERAPEUTICS INC | PLRX | 46,200 | $496,650 | 0.42% |
| 28 | RAPPORT THERAPEUTICS INC | RAPP | 20,000 | $465,200 | 0.39% |
| 29 | NEWAMSTERDAM PHARMA CO NV | NAMSW | 22,500 | $432,225 | 0.36% |
| 30 | LEAP THERAPEUTICS INC | CYPH | 195,000 | $382,200 | 0.32% |
| 31 | CELLECTAR BIOSCIENCES INC. | CLRB | 70,500 | $176,250 | 0.15% |
| 32 | SAVARA INC | SVRA | 250 | $100,750 | 0.08% |
| 33 | NUVATION BIO INC -CW27 | NUVB | 90,832 | $14,533 | 0.01% |